• Cromore Road, Coleraine Campus

    BT52 1SA Coleraine

    United Kingdom

  • 3380 Citations
  • 35 h-Index
1994 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Professor Finbarr O'Harte holds a BSc Hons and PhD from Queen’s University Belfast. He was a Research Fellow at Creighton University, Omaha, USA (1989-91), University College Cork (1992-93) and Ulster University  (1993-95) before taking up an academic appointment as Lecturer in Human Nutrition at Ulster University in 1995. He was promoted to Reader in 2000 and Professor of Endocrinology and Metabolism in 2005. Finbarr is a patent holder and academic co-founder of Diabetica Limted, an Ulster University start-up company focused on innovative diabetes therapeutics. He has over 180 peer-reviewed publications (h-index 36 on Scopus) with many presentations at national and international conferences and was recipient of the Nordisk Medal of the Irish Endocrine Society (2005). He currently holds the position of the President of the Irish Endocrine Society. Research Interests include structurally modified peptides in therapy and drug development. Regulatory peptides in control of feeding and obesity. Incretin hormone analogues in diabetes therapy. Glucagon receptor antagonists in diabetes therapy. Teaching Interests include Diabetes Metabolism and Therapeutics. Hormone Action and Endocrinology. Administrative Roles: Module Co-ordinator for Biochemistry and Molecular Nutrition (NUT502), Biochemical and Molecular Approaches to Nutrition (NUT802). MRes pathway leader for Biomedical Sciences, Biochemistry (BMS102), Final year Reserach projects (NUT507), MSc Research Project in Biomedical Sciences DL (BMS809).

Education/Academic qualification


Queen's University Belfast

1 Oct 198619 Dec 1989

Queen's University Belfast

1 Oct 19821 Jul 1986

External positions

President Irish Endocrine Society

1 Nov 201531 Oct 2018

Fingerprint Dive into the research topics where Finbarr O'Harte is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 28 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 3380 Citations
  • 35 h-Index
  • 200 Article
  • 4 Conference contribution
  • Identification and characterisation of peptides from a boarfish (Capros aper) protein hydrolysate displaying in vitro dipeptidyl peptidase-IV (DPP-IV) inhibitory and insulinotropic activity

    Harnedy-Rothwell, PA., McLaughlin, C., O’Keeffe, MB., Le Gouic, AV., Allsopp, P. J., McSorley, E. M., Sharkey, S., Whooley, J., McGovern, B., O'Harte, F. & Fitzgerald, RJ., 1 May 2020, In : Food Research International. 131, 108989.

    Research output: Contribution to journalArticle

  • 2 Citations (Scopus)

    Stability to thermal treatment of dipeptidyl peptidase IV (DPP-IV) inhibitory activity of a boarfish (Capros aper) protein hydrolysate when incorporated into tomato-based products

    Harnedy-Rothwell, PA., McLaughlin, C., Crowe, W., Allsopp, P. J., McSorley, E. M., Devaney, M., Whooley, J., McGovern, B., V, P., O'Harte, F. & Fitzgerald, R., 1 May 2020, (Accepted/In press) In : International Journal of Food Science and Technology. xx, xx, p. xx xx.

    Research output: Contribution to journalArticle

  • 1 Citation (Scopus)

    Apelin-13 analogues show potent in vitro and in vivo insulinotropic and glucose lowering actions

    O'Harte, F., Parthsarathy, V., Hogg, C. & Flatt, P., 3 Feb 2018, In : Peptides. 100, p. 219-228

    Research output: Contribution to journalArticle

    Open Access
  • 7 Citations (Scopus)


    Exploring the antidiabetic potential of protein hydrolysates derived from underutilized marine sources

    Author: McLaughlin, C., Nov 2018

    Supervisor: O'Harte, F. (Supervisor) & Allsopp, P. J. (Supervisor)

    Student thesis: Doctoral Thesis